Home/Filings/4/0001209191-23-018043
4//SEC Filing

Owens Daniel E. 4

Accession 0001209191-23-018043

CIK 0001630627other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 9:00 PM ET

Size

9.8 KB

Accession

0001209191-23-018043

Insider Transaction Report

Form 4
Period: 2023-03-09
Owens Daniel E.
Chief HR Officer
Transactions
  • Sale

    Common Stock

    2023-03-09$24.41/sh411$10,03310,289 total
  • Award

    Common Stock

    2023-03-10+20,62530,914 total
  • Award

    Stock Option Right to Buy

    2023-03-10+46,75046,750 total
    Exercise: $24.07Exp: 2033-03-10Stock Option Right to Buy (46,750 underlying)
Footnotes (5)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F2]Includes 5,025 RSUs.
  • [F3]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
  • [F4]Includes 25,650 RSUs.
  • [F5]The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001858105

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 9:00 PM ET
Size
9.8 KB